Compare ALVO & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | RVLV |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 2018 |
| Metric | ALVO | RVLV |
|---|---|---|
| Price | $3.46 | $22.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $8.00 | ★ $29.73 |
| AVG Volume (30 Days) | ★ 1.1M | 944.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.64 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $1,225,682,000.00 |
| Revenue This Year | $13.28 | $10.96 |
| Revenue Next Year | $18.63 | $8.01 |
| P/E Ratio | ★ $18.20 | $113.10 |
| Revenue Growth | N/A | ★ 8.48 |
| 52 Week Low | $2.94 | $17.35 |
| 52 Week High | $9.94 | $31.68 |
| Indicator | ALVO | RVLV |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 56.36 |
| Support Level | $3.09 | $20.60 |
| Resistance Level | $3.83 | $22.92 |
| Average True Range (ATR) | 0.23 | 1.01 |
| MACD | -0.05 | 0.17 |
| Stochastic Oscillator | 5.06 | 61.09 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.